Nathan B Fountain - Net Worth and Insider Trading
Nathan B Fountain Net Worth
The estimated net worth of Nathan B Fountain is at least $22,813 dollars as of 2024-05-17. Nathan B Fountain is the Director of Acumen Pharmaceuticals Inc and owns about 6,250 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $22,813. Details can be seen in Nathan B Fountain's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nathan B Fountain has not made any transactions after 2021-07-06 and currently still holds the listed stock(s).
Transaction Summary of Nathan B Fountain
Nathan B Fountain Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nathan B Fountain owns 1 companies in total, including Acumen Pharmaceuticals Inc (ABOS) .
Click here to see the complete history of Nathan B Fountain’s form 4 insider trades.
Insider Ownership Summary of Nathan B Fountain
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | director |
Nathan B Fountain Latest Holdings Summary
Nathan B Fountain currently owns a total of 1 stock. Nathan B Fountain owns 6,250 shares of Acumen Pharmaceuticals Inc (ABOS) as of July 6, 2021, with a value of $22,813.
Latest Holdings of Nathan B Fountain
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 6,250 | 3.65 | 22,813 |
Holding Weightings of Nathan B Fountain
Nathan B Fountain Form 4 Trading Tracker
According to the SEC Form 4 filings, Nathan B Fountain has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the acquisition of 6,250 shares on July 6, 2021, which cost Nathan B Fountain around $100,000.
Insider Trading History of Nathan B Fountain
- 1
Nathan B Fountain Trading Performance
GuruFocus tracks the stock performance after each of Nathan B Fountain's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nathan B Fountain is -26.49%. GuruFocus also compares Nathan B Fountain's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nathan B Fountain within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nathan B Fountain's insider trading performs compared to the benchmark.
Performance of Nathan B Fountain
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.69 | | | | | |
| Relative Return to S&P 500(%) | -27.83 | | | | | |
Nathan B Fountain Ownership Network
Nathan B Fountain Owned Company Details
What does Acumen Pharmaceuticals Inc do?
Who are the key executives at Acumen Pharmaceuticals Inc?
Nathan B Fountain is the director of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Legal Office & Corp Sec Derek M Meisner , director & President and CEO Daniel Joseph Oconnell , and Chief Financial Officer Matt Zuga .
Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary
Over the past 18 months, Nathan B Fountain made no insider transaction in Acumen Pharmaceuticals Inc (ABOS). Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 15,200 shares made by Daniel Joseph Oconnell .
In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.
Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acumen Pharmaceuticals Inc Insider Transactions
Nathan B Fountain Mailing Address
Above is the net worth, insider trading, and ownership report for Nathan B Fountain. You might contact Nathan B Fountain via mailing address: C/o Acumen Pharmaceuticals, Inc., 427 Park Street, Charlottesville Va 22902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
